{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Endoscopy+tissue+collection", "query": { "intervention": "Endoscopy tissue collection" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 60, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Endoscopy+tissue+collection&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-07T00:01:24.601Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03781596", "title": "EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Eosinophilic Esophagitis" ], "interventions": [ { "name": "Retrospective evaluation of endoscopy prior to study drug", "type": "DIAGNOSTIC_TEST" }, { "name": "Symptom Survey", "type": "OTHER" }, { "name": "Medication Compliance Phone Call", "type": "OTHER" }, { "name": "Endoscopy while on study drug", "type": "DIAGNOSTIC_TEST" }, { "name": "Fluticasone", "type": "DRUG" }, { "name": "Omeprazole", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "OTHER", "DRUG" ], "sponsor": "Claire Daniels", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "6 Years to 60 Years" }, "enrollment_count": 100, "start_date": "2018-10-02", "completion_date": "2022-10-02", "has_results": false, "last_update_posted_date": "2018-12-20", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03781596" }, { "nct_id": "NCT00899457", "title": "Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy, no Evidence of Disease", "Lung Cancer" ], "interventions": [ { "name": "proteomic profiling", "type": "GENETIC" }, { "name": "biologic sample preservation procedure", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "bronchoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "GENETIC", "OTHER", "PROCEDURE" ], "sponsor": "Vanderbilt-Ingram Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2008-04", "completion_date": "2010-08", "has_results": false, "last_update_posted_date": "2014-06-24", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 3, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00899457" }, { "nct_id": "NCT04295811", "title": "Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Barrett Esophagus", "Esophageal Adenocarcinoma", "Barretts Esophagus With Dysplasia", "Barrett's Esophagus Without Dysplasia" ], "interventions": [ { "name": "EsoGuard (lab assay)", "type": "DEVICE" }, { "name": "Esophagogastroduodenoscopy", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DEVICE", "DIAGNOSTIC_TEST" ], "sponsor": "Lucid Diagnostics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "MALE", "summary": "50 Years and older · Male only" }, "enrollment_count": 470, "start_date": "2020-06-18", "completion_date": "2023-12", "has_results": false, "last_update_posted_date": "2023-01-25", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 32, "location_summary": "Birmingham, Alabama • Orange, California • Aurora, Colorado + 27 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Orange", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04295811" }, { "nct_id": "NCT05058846", "title": "Pilot Study of Pancreatic Cancer Screening", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pancreatic Carcinoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Cholangiopancreatography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Endoscopic ultrasound", "type": "PROCEDURE" }, { "name": "Questionnaires", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2022-01-20", "completion_date": "2032-01-31", "has_results": false, "last_update_posted_date": "2026-08-11", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05058846" }, { "nct_id": "NCT05874726", "title": "Biological Sample Repository for Gastrointestinal Disorders", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obesity", "Obesity, Morbid", "Obesity, Primary", "Gastro-Intestinal Disorder", "Overweight and Obesity", "Overweight", "Overweight or Obesity", "Diabetes Type 2", "Diabetes Mellitus", "Diabetes Mellitus, Type 2", "Hypertension", "Hyperlipidemias", "Sleep Apnea", "GERD", "Gastroesophageal Reflux", "Musculoskeletal Pain Disorder", "Cancer" ], "interventions": [ { "name": "Blood Collection", "type": "DIAGNOSTIC_TEST" }, { "name": "Urine Collection", "type": "DIAGNOSTIC_TEST" }, { "name": "Tissue Sample Collection", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Pichamol Jirapinyo, MD, MPH", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 500, "start_date": "2023-07-19", "completion_date": "2029-04", "has_results": false, "last_update_posted_date": "2025-12-02", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05874726" }, { "nct_id": "NCT02000089", "title": "The Cancer of the Pancreas Screening-5 CAPS5)Study", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pancreas Cancer", "Peutz-Jeghers Syndrome (PJS)", "Gene Mutation", "Germline Mutation Carrier", "Lynch Syndrome" ], "interventions": [ { "name": "Secretin", "type": "DRUG" }, { "name": "MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "Tumor marker gene test with CA19-9", "type": "OTHER" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST", "OTHER" ], "sponsor": "Johns Hopkins University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9000, "start_date": "2014-01-06", "completion_date": "2029-06", "has_results": false, "last_update_posted_date": "2025-10-09", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 9, "location_summary": "New Haven, Connecticut • Baltimore, Maryland • Boston, Massachusetts + 5 more", "locations": [ { "city": "New Haven", "state": "Connecticut" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02000089" }, { "nct_id": "NCT02371135", "title": "Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lynch Syndrome", "Hereditary Colonic Polyposis Syndromes" ], "interventions": [ { "name": "colonic biopsies", "type": "GENETIC" }, { "name": "questionnaires", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 77, "start_date": "2015-02", "completion_date": "2027-02", "has_results": false, "last_update_posted_date": "2026-02-05", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02371135" }, { "nct_id": "NCT07471490", "title": "Specimen and Data Collection for a Novel Biomarker Combination for the Differential Diagnosis of Inflammatory Bowel Disease and Irritable Bowel Syndrome.", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "IBD (Inflammatory Bowel Disease)", "IBS (Irritable Bowel Syndrome)", "Gastrointestinal Symptoms" ], "interventions": [], "intervention_types": [], "sponsor": "DiaSorin Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 300, "start_date": "2025-05-07", "completion_date": "2026-09-01", "has_results": false, "last_update_posted_date": "2026-03-13", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07471490" }, { "nct_id": "NCT05630794", "title": "Testing for Safety and Colorectal Cancer Preventive Effects of ONC201", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Colorectal Adenomatous Polyp", "Colorectal Carcinoma", "Familial Adenomatous Polyposis", "Multiple Adenomatous Polyps" ], "interventions": [ { "name": "Biopsy Procedure", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Colonoscopy", "type": "PROCEDURE" }, { "name": "Dordaviprone Hydrochloride", "type": "DRUG" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Sigmoidoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2025-10-06", "completion_date": "2028-03-01", "has_results": false, "last_update_posted_date": "2026-06-12", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 5, "location_summary": "Ann Arbor, Michigan • St Louis, Missouri • Cleveland, Ohio + 2 more", "locations": [ { "city": "Ann Arbor", "state": "Michigan" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT05630794" }, { "nct_id": "NCT01869634", "title": "Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Human Immunodeficiency Virus Infection" ], "interventions": [ { "name": "darunavir with ritonavir and fixed-dose viread+emtricitabine daily", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, Davis", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 37, "start_date": "2013-06", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2020-03-04", "last_synced_at": "2026-09-07T00:01:24.601Z", "location_count": 1, "location_summary": "Sacramento, California", "locations": [ { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01869634" } ] }